{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T05:25:28Z","timestamp":1787981128875,"version":"build-2784847793"},"reference-count":21,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T00:00:00Z","timestamp":1606089600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"European Union\u2019s Horizon 2020 Research and Innovation Program","award":["643578"],"award-info":[{"award-number":["643578"]}]},{"name":"European Union\u2019s Horizon 2020 Research and Innovation Program","award":["779257"],"award-info":[{"award-number":["779257"]}]},{"name":"Horizon 2020 Research and Innovation Programme"},{"name":"DOCPRO4 Antwerp University Research Fund","award":["DOCPRO2016\u201333497"],"award-info":[{"award-number":["DOCPRO2016\u201333497"]}]},{"name":"E. von Behring Chair for Neuromuscular and Neurodegenerative Disorders"},{"name":"ALS Liga Belgi\u00eb and the KU Leuven funds \u201cEen Hart voor ALS\u201d"},{"name":"Laeversfonds voor ALS Onderzoek\u201d and the \u201cVal\u00e9ry Perrier Race against ALS Fund"},{"name":"Senior Clinical Researcher mandate of the Research Fund - Flanders","award":["1805016N"],"award-info":[{"award-number":["1805016N"]}]},{"name":"European Reference Network for Rare Neuromuscular Diseases"},{"name":"European Reference Network for Rare Neurological Diseases"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,3,3]]},"DOI":"10.1093\/brain\/awaa389","type":"journal-article","created":{"date-parts":[[2020,10,26]],"date-time":"2020-10-26T20:39:31Z","timestamp":1603744771000},"page":"e17-e17","source":"Crossref","is-referenced-by-count":14,"title":["<i>PCYT2<\/i> mutations disrupting etherlipid biosynthesis: phenotypes converging on the CDP-ethanolamine pathway"],"prefix":"10.1093","volume":"144","author":[{"given":"Jonathan","family":"De Winter","sequence":"first","affiliation":[{"name":"Neuromuscular Reference Centre, Department of Neurology, Antwerp University Hospital, Antwerpen, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6593-7644","authenticated-orcid":false,"given":"Danique","family":"Beijer","sequence":"additional","affiliation":[{"name":"Translational Neurosciences, Faculty of Medicine and Health Sciences, UAntwerpen, Antwerp, Belgium"},{"name":"Laboratory of Neuromuscular Pathology, Institute Born-Bunge, University of Antwerp, Antwerpen, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willem","family":"De Ridder","sequence":"additional","affiliation":[{"name":"Neuromuscular Reference Centre, Department of Neurology, Antwerp University Hospital, Antwerpen, Belgium"},{"name":"Translational Neurosciences, Faculty of Medicine and Health Sciences, UAntwerpen, Antwerp, Belgium"},{"name":"Laboratory of Neuromuscular Pathology, Institute Born-Bunge, University of Antwerp, Antwerpen, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthis","family":"Synofzik","sequence":"additional","affiliation":[{"name":"Department of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research and Center of Neurology, University of T\u00fcbingen, T\u00fcbingen, Germany"},{"name":"German Center for Neurodegenerative Diseases (DZNE), T\u00fcbingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5669-7415","authenticated-orcid":false,"given":"Stephan L","family":"Zuchner","sequence":"additional","affiliation":[{"name":"Dr. John T Macdonald Foundation Department of Human Genetics and Hussman Institute for Human Genomics, Miller School of Medicine, University of Miami, Miami, FL 33136, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"PREPARE consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4010-2357","authenticated-orcid":false,"given":"Philip","family":"Van Damme","sequence":"additional","affiliation":[{"name":"KU Leuven \u2013 University of Leuven, Department of Neurosciences, Experimental Neurology, and Leuven Brain Institute (LBI), Leuven, Belgium"},{"name":"VIB, Center for Brain and Disease Research, Laboratory of Neurobiology, Leuven, Belgium"},{"name":"University Hospitals Leuven, Department of Neurology, Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner","family":"Spileers","sequence":"additional","affiliation":[{"name":"University Hospitals Leuven, Department of Ophthalmology, Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Baets","sequence":"additional","affiliation":[{"name":"Neuromuscular Reference Centre, Department of Neurology, Antwerp University Hospital, Antwerpen, Belgium"},{"name":"Translational Neurosciences, Faculty of Medicine and Health Sciences, UAntwerpen, Antwerp, Belgium"},{"name":"Laboratory of Neuromuscular Pathology, Institute Born-Bunge, University of Antwerp, Antwerpen, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,11,23]]},"reference":[{"key":"2021030904210692900_awaa389-B1","first-page":"547","article-title":"A mutation of EPT1 (SELENOI) underlies a new disorder of Kennedy pathway phospholipid biosynthesis","volume":"140","author":"Ahmed","year":"2017","journal-title":"Brain"},{"key":"2021030904210692900_awaa389-B2","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s10048-011-0291-8","article-title":"A nullimorphic ERLIN2 mutation defines a complicated hereditary spastic paraplegia locus (SPG18)","volume":"12","author":"Alazami","year":"2011","journal-title":"Neurogenetics"},{"key":"2021030904210692900_awaa389-B3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2013.02.026","article-title":"A rare family with Hereditary Spastic Paraplegia Type 35 due to novel FA2H mutations: a case report with literature review","volume":"329","author":"Cao","year":"2013","journal-title":"J Neurol Sci"},{"key":"2021030904210692900_awaa389-B4","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3389\/fnins.2020.00074","article-title":"Lipids in the physiopathology of hereditary spastic paraplegias","volume":"14","author":"Darios","year":"2020","journal-title":"Front Neurosci"},{"key":"2021030904210692900_awaa389-B5","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1093\/brain\/awp073","article-title":"CYP7B1 mutations in pure and complex forms of hereditary spastic paraplegia type 5","volume":"132","author":"Goizet","year":"2009","journal-title":"Brain"},{"key":"2021030904210692900_awaa389-B6","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1002\/humu.22836","article-title":"Innovative genomic collaboration using the GENESIS (GEM.app) platform","volume":"36","author":"Gonzalez","year":"2015","journal-title":"Hum Mutat"},{"key":"2021030904210692900_awaa389-B7","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ajhg.2013.11.018","article-title":"Mutations in PCYT1A, encoding a key regulator of phosphatidylcholine metabolism, cause spondylometaphyseal dysplasia with cone-rod dystrophy","volume":"94","author":"Hoover-Fong","year":"2014","journal-title":"Am J Hum Genet"},{"key":"2021030904210692900_awaa389-B8","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1002\/1873-3468.12919","article-title":"From yeast to humans - roles of the Kennedy pathway for phosphatidylcholine synthesis","volume":"592","author":"McMaster","year":"2018","journal-title":"FEBS Lett"},{"key":"2021030904210692900_awaa389-B9","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.ajhg.2007.12.018","article-title":"Neuropathy target esterase gene mutations cause motor neuron disease","volume":"82","author":"Rainier","year":"2008","journal-title":"Am J Hum Genet"},{"key":"2021030904210692900_awaa389-B10","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/brain\/awz382","article-title":"Lipid metabolic pathways converge in motor neuron degenerative diseases","volume":"143","author":"Rickman","year":"2020","journal-title":"Brain"},{"key":"2021030904210692900_awaa389-B11","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1136\/jmedgenet-2017-104622","article-title":"SERAC1 deficiency causes complicated HSP: evidence from a novel splice mutation in a large family","volume":"55","author":"Roeben","year":"2018","journal-title":"J Med Genet"},{"key":"2021030904210692900_awaa389-B12","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.ajhg.2012.10.017","article-title":"Mutations in DDHD2, encoding an intracellular phospholipase A(1), cause a recessive form of complex hereditary spastic paraplegia","volume":"91","author":"Schuurs-Hoeijmakers","year":"2012","journal-title":"Am J Hum Genet"},{"key":"2021030904210692900_awaa389-B13","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/S1474-4422(19)30235-2","article-title":"Hereditary spastic paraplegia: from diagnosis to emerging therapeutic approaches","volume":"18","author":"Shribman","year":"2019","journal-title":"Lancet Neurol"},{"key":"2021030904210692900_awaa389-B14","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/brain\/awt326","article-title":"PNPLA6 mutations cause Boucher-Neuhauser and Gordon Holmes syndromes as part of a broad neurodegenerative spectrum","volume":"137","author":"Synofzik","year":"2014","journal-title":"Brain"},{"key":"2021030904210692900_awaa389-B15","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/mds.26944","article-title":"Overcoming the divide between ataxias and spastic paraplegias: shared phenotypes, genes, and pathways","volume":"32","author":"Synofzik","year":"2017","journal-title":"Mov Disord"},{"key":"2021030904210692900_awaa389-B16","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.ajhg.2012.11.001","article-title":"Alteration of fatty-acid-metabolizing enzymes affects mitochondrial form and function in hereditary spastic paraplegia","volume":"91","author":"Tesson","year":"2012","journal-title":"Am J Hum Genet"},{"key":"2021030904210692900_awaa389-B17","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/ejhg.2017.23","article-title":"Mutations in the PCYT1A gene are responsible for isolated forms of retinal dystrophy","volume":"25","author":"Testa","year":"2017","journal-title":"Eur J Hum Genet"},{"key":"2021030904210692900_awaa389-B18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/tra.12230","article-title":"Phospholipid synthesis and transport in mammalian cells","volume":"16","author":"Vance","year":"2015","journal-title":"Traffic"},{"key":"2021030904210692900_awaa389-B19","doi-asserted-by":"crossref","first-page":"3382","DOI":"10.1093\/brain\/awz291","article-title":"Mutations in PCYT2 disrupt etherlipid biosynthesis and cause a complex hereditary spastic paraplegia","volume":"142","author":"Vaz","year":"2019","journal-title":"Brain"},{"key":"2021030904210692900_awaa389-B20","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/ng1313","article-title":"Heterozygous missense mutations in BSCL2 are associated with distal hereditary motor neuropathy and Silver syndrome","volume":"36","author":"Windpassinger","year":"2004","journal-title":"Nat Genet"},{"key":"2021030904210692900_awaa389-B21","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ajhg.2013.11.022","article-title":"Mutations in PCYT1A cause spondylometaphyseal dysplasia with cone-rod dystrophy","volume":"94","author":"Yamamoto","year":"2014","journal-title":"Am J Hum Genet"}],"container-title":["Brain"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/brain\/article-pdf\/144\/2\/e17\/36454359\/awaa389.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/brain\/article-pdf\/144\/2\/e17\/36454359\/awaa389.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,9]],"date-time":"2021-03-09T04:21:54Z","timestamp":1615263714000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/brain\/article\/144\/2\/e17\/5999114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,23]]},"references-count":21,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,11,23]]},"published-print":{"date-parts":[[2021,3,3]]}},"URL":"https:\/\/doi.org\/10.1093\/brain\/awaa389","relation":{},"ISSN":["0006-8950","1460-2156"],"issn-type":[{"value":"0006-8950","type":"print"},{"value":"1460-2156","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,2,1]]},"published":{"date-parts":[[2020,11,23]]}}}